Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site — Stella

View on ClinicalTrials.gov

Recruiting

Back to NSCLC trials

Trial locations(1 site)

Italy

Istituto Europeo di Oncologia, Milan

Key details

Sponsor

European Institute of Oncology

Enrollment target

~25 participants

Started

December 2025

Primary completion

June 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.